Skip to main content
CRESCENT BIOPHARMA, INC. logo

CRESCENT BIOPHARMA, INC. — Investor Relations & Filings

Ticker · CBIO ISIN · US38000Q1022 US Manufacturing
Filings indexed 611 across all filing types
Latest filing 2026-02-26 Regulatory Filings
Country US United States of America
Listing US CBIO

About CRESCENT BIOPHARMA, INC.

https://www.crescentbiopharma.com/

Crescent Biopharma, Inc. is a biopharmaceutical company dedicated to researching and developing the next wave of cancer therapies. The company's vision is to build a world-leading oncology organization by focusing on revolutionary shifts in the field to transform cancer treatment. Its strategy involves advancing a pipeline of therapies with multiple modalities, including precision-engineered small molecule therapeutics, designed to address cancer on various fronts. Crescent Biopharma aims to deliver a new standard of care for people living with cancer through its innovative pipeline.

Recent filings

Filing Released Lang Actions
8-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)
Regulatory Filings
2026-02-26 English
10-K - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)
Annual Report FY 2025
2026-02-26 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-05 English
424B3 Filing
Prospectus
2026-01-15 English
S-1 Filing
Registration Form
2026-01-07 English
FORM 4
Director's Dealing
2025-12-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.